시장보고서
상품코드
1889566

세계의 스캐폴드 프리 3D 세포배양 시장 보고서(2025년)

Scaffold Free 3D Cell Culture Global Market Report 2025

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

스캐폴드 프리 3D 세포배양 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 7억 5,000만 달러로 평가되었고, 2025년에는 8억 5,000만 달러에 달할 것으로 추정되며, CAGR 12.4%로 성장이 예상되고 있습니다. 지금까지의 성장은 독성시험에서의 스캐폴드 프리 모델 이용 증가, 비용 효율적인 전임상 모델 수요 증가, 예측 정밀도가 높은 약제 시험에 대한 수요 증가, 학술계 및 산업계에서의 3D 연구 확대, 그리고 선진적인 세포배양 연구에 대한 정부 자금 증가에 기인하고 있습니다.

스캐폴드 프리 3D 세포배양 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년에는 13억 3,000만 달러에 달할 것으로 예측되며, CAGR 12.0%로 성장할 전망입니다. 예측 기간의 성장 요인으로는 환자 유래 유기체의 채용 확대, 개별화 약물 스크리닝의 필요성 증가, 스캐폴드 프리 구상체 분석 수요 증가, 의약품 연구 파이프라인 확대, 합리적인 의료 용도에 있어서의 진보 등을 들 수 있습니다. 예측 기간 동안 예상되는 주요 동향은 마이크로플루이딕스 3D 배양 시스템의 혁신, 바이오리액터 및 자동화 플랫폼의 기술적 진보, 공배양 및 다세포 모델의 개발, 질병 특이적 오가노이드의 연구개발 증가, 3D 배양을 위한 고 컨텐츠 이미징 및 분석의 진전을 포함합니다.

맞춤형 의료의 성장은 향후 수년간 스캐폴드 프리 3D 세포배양 시장의 확대를 이끌 것으로 예측됩니다. 맞춤형 의료는 개인의 유전적 요인, 환경 요인, 생활 습관에 따라 치료법 및 의료 판단을 사용자 정의합니다. 그 성장은 유전체학, 생명공학, 데이터 분석의 진보에 의해 촉진되어 보다 정밀하고 효과적인 맞춤형 치료를 가능하게 하고 있습니다. 스캐폴드 프리 3D 세포배양 기술은 환자 고유의 조직 모델을 창출함으로써 맞춤형 의료를 지원하고 정확한 약물 시험과 개인화된 치료 전략을 가능하게 합니다. 예를 들어 2024년 2월 미국 비영리 단체 '맞춤형 의료연합'이 보고한 바에 따르면 2023년에는 FDA가 희소질환 환자를 위한 신규 맞춤형 치료를 16건 승인하였고, 2022년 6건에서 증가했습니다. 따라서 맞춤형 의료의 확대가 스캐폴드 프리 3D 세포배양 시장의 성장을 견인하고 있습니다.

스캐폴드 프리 3D 세포배양 시장의 주요 기업은 창약이나 암 연구의 효율화를 도모하기 위해, 스페로이드 형성이나 모니터링 등의 분야에서 기술 혁신을 진행하고 있습니다. 광학적으로 투명한 플라스크 밑면, 균일한 마이크로 캐비티 설계, 하이 스루풋 포맷 등의 기술로 3D 세포배양의 가시성, 재현성, 스케일 업이 향상되었습니다. 예를 들어, 2024년 2월에는 미국에 본사를 둔 생명 과학 기업인 코닝사가 '코닝 엘프라지아 12K 플라스크'를 발표했습니다. 이 플라스크는 플라스크 당 약 1만 2,000개의 균일한 스페로이드의 생산을 지원하며 기존의 96웰 플레이트와 비교하여 스페로이드 크기의 균일성 향상, 재현성 향상 및 수율 증가를 실현합니다. 종양세포, 정상세포, 초대세포 등 다양한 세포 유형에 대응하고 있으며, 약제 스크리닝, 암 연구, 선진적 치료법의 개발에 유용합니다.

자주 묻는 질문

  • 스캐폴드 프리 3D 세포배양 시장 규모는 어떻게 변화하고 있나요?
  • 스캐폴드 프리 3D 세포배양 시장의 주요 성장 요인은 무엇인가요?
  • 맞춤형 의료의 성장은 스캐폴드 프리 3D 세포배양 시장에 어떤 영향을 미치고 있나요?
  • 스캐폴드 프리 3D 세포배양 시장의 주요 기업은 어떤 곳이 있나요?
  • 스캐폴드 프리 3D 세포배양 시장에서의 기술 혁신은 어떤 방향으로 진행되고 있나요?

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

  • 세계의 스캐폴드 프리 3D 세포배양 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
  • 최종 이용 산업의 분석
  • 세계의 스캐폴드 프리 3D 세포배양 시장 : 성장률 분석
  • 세계의 스캐폴드 프리 3D 세포배양 시장 실적 : 규모 및 성장(2019-2024년)
  • 세계의 스캐폴드 프리 3D 세포배양 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
  • 세계의 스캐폴드 프리 3D 세포배양 : 총 잠재 시장 규모(TAM)

제6장 시장 세분화

  • 세계의 스캐폴드 프리 3D 세포배양 시장 : 제품 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
  • 3D 세포배양 플랫폼
  • 3D 바이오프린팅 제품
  • 3D 세포배양 키트
  • 마이크로플루이딕스 장치
  • 세계의 스캐폴드 프리 3D 세포배양 시장 : 세포 컴포넌트별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
  • 줄기세포
  • 부착 세포배양
  • 현탁 세포배양
  • 면역세포
  • 세계의 스캐폴드 프리 3D 세포배양 시장 : 기술별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
  • 서스펜션법
  • 자기 부상
  • 마이크로플루이딕스 기술
  • 세계의 스캐폴드 프리 3D 세포배양 시장 : 용도별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
  • 창약
  • 재생 의료
  • 조직공학
  • 종양학 조사
  • 줄기세포 연구
  • 세계의 스캐폴드 프리 3D 세포배양 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
  • 학술연구기관
  • 제약 및 생명 공학 기업
  • 수탁연구기관(CRO)
  • 진료소 및 병원
  • 세계의 스캐폴드 프리 3D 세포배양 시장 : 3D 세포배양 플랫폼 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
  • 서스펜션 플레이트
  • 저접착성 마이크로플레이트
  • 초저부착(ULA) 플레이트 및 플라스크
  • 스페로이드 배양 접시
  • 스피너 플라스크 및 바이오리액터
  • 현탁 배양 시스템
  • 세계의 스캐폴드 프리 3D 세포배양 시장 : 3D 바이오프린팅 제품 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
  • 바이오프린터
  • 바이오잉크
  • 프린트 헤드 및 노즐
  • 인쇄 소프트웨어
  • 소모품 및 부속품
  • 세계의 스캐폴드 프리 3D 세포배양 시장 : 3D 세포배양 키트 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
  • 스페로이드 형성 키트
  • 오가노이드 배양 키트
  • 공배양 키트
  • 종양 모델 키트
  • 줄기세포 분화 키트
  • 분석 대응 3D 세포배양 키트
  • 세계의 스캐폴드 프리 3D 세포배양 시장 : 마이크로플루이딕스 디바이스 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
  • 장기 온칩 시스템
  • 랩 온 어 칩 플랫폼
  • 마이크로 챔버 어레이
  • 관류형 마이크로플루이딕스 장치
  • 액적 기반 마이크로플루이딕스 시스템
  • 그라디언트 생성 마이크로플루이딕스 장치

제7장 지역별 및 국가별 분석

  • 세계의 스캐폴드 프리 3D 세포배양 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
  • 세계의 스캐폴드 프리 3D 세포배양 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

  • 스캐폴드 프리 3D 세포배양 시장 : 경쟁 구도
  • 스캐폴드 프리 3D 세포배양 시장 : 기업 프로파일
    • Thermo Fisher Scientific Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
    • Merck KGaA : 개요, 제품 및 서비스, 전략 및 재무 분석
    • Corning Incorporated : 개요, 제품 및 서비스, 전략 및 재무 분석
    • Lonza Group AG : 개요, 제품 및 서비스, 전략 및 재무 분석
    • Sartorius AG : 개요, 제품 및 서비스, 전략 및 재무 분석

제31장 기타 주요 기업 및 혁신 기업

  • Hamilton Company
  • CELLINK AB
  • Creative Bioarray Inc.
  • InSphero AG
  • Creative Biolabs Inc.
  • Mimetas BV
  • REPROCELL Inc.
  • Synthecon Incorporated
  • Advanced Solutions Life Sciences LLC
  • Cherry Biotech SAS
  • celVivo ApS
  • Elveflow
  • Guangzhou Jet Bio-Filtration Co. Ltd.
  • Organovo Holdings Inc.
  • Alfa Cytology Co. Ltd.

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

  • 스캐폴드 프리 3D 세포배양 시장(2029년) : 새로운 기회를 제공하는 국가
  • 스캐폴드 프리 3D 세포배양 시장(2029년) : 새로운 기회를 제공하는 부문
  • 스캐폴드 프리 3D 세포배양 시장(2029년) : 성장 전략
    • 시장 동향에 기초한 전략
    • 경쟁 전략

제36장 부록

AJY

Scaffold-free 3D cell culture is a technique that enables cells to grow and self-assemble into three-dimensional structures without relying on external scaffolding materials. This method depends on the cells' natural ability to adhere to one another and form spheroids or organoid-like structures, more accurately replicating the architecture and function of native tissues. It provides a physiologically relevant environment for studying cell behavior, tissue development, and drug responses.

The main product types in scaffold-free 3D cell culture include 3D cell culture platforms, 3D bioprinting products, 3D cell culture kits, and microfluidic devices. 3D cell culture platforms are advanced systems that support cell growth and interaction in three dimensions without scaffolding materials, closely simulating natural tissue architecture and function. Key cellular components include stem cells, adherent cell cultures, suspension cell cultures, and immune cells. Major techniques used are the hanging drop method, magnetic levitation, and microfluidics. Key applications include drug discovery, regenerative medicine, tissue engineering, oncology research, and stem cell research, with primary end users comprising academic research institutions, pharmaceutical and biotechnology companies, contract research organizations (CROs), and clinics and hospitals.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The scaffold free 3D cell culture market research report is one of a series of new reports from The Business Research Company that provides scaffold free 3D cell culture market statistics, including the scaffold free 3D cell culture industry global market size, regional shares, competitors with the scaffold free 3D cell culture market share, detailed scaffold free 3D cell culture market segments, market trends, and opportunities, and any further data you may need to thrive in the scaffold free 3D cell culture industry. This scaffold free 3D cell culture market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The scaffold free 3D cell culture market size has grown rapidly in recent years. It will grow from $0.75 billion in 2024 to $0.85 billion in 2025 at a compound annual growth rate (CAGR) of 12.4%. Growth during the historic period can be attributed to increasing use of scaffold-free models in toxicity testing, the growing need for cost-effective preclinical models, rising demand for more predictive drug testing, the expansion of academic and industrial 3D research, and increased government funding for advanced cell-culture studies.

The scaffold free 3D cell culture market size is expected to see rapid growth in the next few years. It will grow to $1.33 billion in 2029 at a compound annual growth rate (CAGR) of 12.0%. Growth in the forecast period can be attributed to the growing adoption of patient-derived organoids, rising requirements for personalized drug screening, increasing demand for scaffold-free spheroid assays, expansion of pharmaceutical research pipelines, and advancements in rational medicine applications. Major trends expected in the forecast period include innovations in microfluidic 3D culture systems, technological advancements in bioreactors and automated platforms, developments in co-culture and multicellular models, increased research and development in disease-specific organoids, and progress in high-content imaging and analysis for 3D cultures.

The growth of personalized medicine is expected to drive the expansion of the scaffold-free 3D cell culture market in the coming years. Personalized medicine tailors treatments and healthcare decisions based on individual genetic, environmental, and lifestyle factors. Its growth is fueled by advances in genomics, biotechnology, and data analytics, enabling more precise and effective individualized therapies. Scaffold-free 3D cell culture supports personalized medicine by creating patient-specific tissue models, allowing accurate drug testing and tailored therapeutic strategies. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the FDA approved 16 new personalized treatments for patients with rare diseases, up from six approved in 2022. Therefore, the expansion of personalized medicine is driving growth in the scaffold-free 3D cell culture market.

Major companies in the scaffold-free 3D cell culture market are innovating in areas such as spheroid formation and monitoring to enhance efficiency in drug discovery and cancer research. Technologies like optically clear flask bottoms, uniform microcavity designs, and high-throughput formats enable better visualization, reproducibility, and scale of 3D cell cultures. For instance, in February 2024, Corning Incorporated, a US-based life sciences company, introduced the Corning Elplasia 12K flask. This flask supports the production of approximately 12,000 uniform spheroids per flask, offering greater consistency in spheroid size, improved reproducibility, and higher yields compared to traditional 96-well plates. It is compatible with tumor, normal, and primary cell types, making it valuable for drug screening, cancer research, and advanced therapy development.

In January 2025, Merck KGaA, a Germany-based healthcare and life sciences company, acquired HUB Organoids Holding B.V. to strengthen its scaffold-free 3D cell culture capabilities. Through this acquisition, Merck aims to integrate HUB Organoids' patient-derived organoid technology to accelerate and enhance drug discovery and personalized medicine applications. HUB Organoids, based in the Netherlands, specializes in patient-derived organoid models that closely replicate human tissue structure and function for research and therapeutic purposes.

Major companies operating in the scaffold free 3d cell culture market are Thermo Fisher Scientific Inc., Merck KGaA, Corning Incorporated, Lonza Group AG, Sartorius AG, Hamilton Company, CELLINK AB, Creative Bioarray Inc., InSphero AG, Creative Biolabs Inc., Mimetas B.V., REPROCELL Inc., Synthecon Incorporated, Advanced Solutions Life Sciences LLC, Cherry Biotech SAS, celVivo ApS, Elveflow, Guangzhou Jet Bio-Filtration Co. Ltd., Organovo Holdings Inc., Alfa Cytology Co. Ltd.

North America was the largest region in the scaffold free 3D cell culture market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in scaffold free 3D cell culture report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the scaffold free 3D cell culture market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The scaffold free 3D cell culture market consists of sales of 3D cell culture platforms, 3D bioprinting products, 3D cell culture kits, microfluidic devices, spheroid culture plates, magnetic levitation kits, hanging drop plates, organoid culture media, cell culture consumables, and specialized culture ware. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Scaffold Free 3D Cell Culture Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on scaffold free 3d cell culture market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for scaffold free 3d cell culture ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The scaffold free 3d cell culture market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: 3D Cell Culture Platforms; 3D Bioprinting Products; 3D Cell Culture Kits; Microfluidic Devices
  • 2) By Cellular Components: Stem Cells; Adherent Cell Cultures; Suspension Cell Cultures; Immune Cells
  • 3) By Technique: Hanging Drop Method; Magnetic Levitation; Microfluidics
  • 4) By Application: Drug Discovery; Regenerative Medicine; Tissue Engineering; Oncology Research; Stem Cell Research
  • 5) By End-User: Academic Research Institutions; Pharmaceutical And Biotechnology Companies; Contract Research Organizations (CROs); Clinics And Hospitals
  • Subsegments:
  • 1) By 3D Cell Culture Platforms: Hanging Drop Plates; Low-Adhesion Microplates; Ultra-Low Attachment (ULA) Plates And Flasks; Spheroid Culture Dishes; Spinner Flasks And Bioreactors; Suspension Culture Systems
  • 2) By 3D Bioprinting Products: Bioprinters; Bioinks; Printheads And Nozzles; Printing Software; Consumables And Accessories
  • 3) By 3D Cell Culture Kits: Spheroid Formation Kits; Organoid Culture Kits; Co-Culture Kits; Tumor Model Kits; Stem Cell Differentiation Kits; Assay-Ready 3D Cell Culture Kits
  • 4) By Microfluidic Devices: Organ-On-A-Chip Systems; Lab-On-A-Chip Platforms; Microchamber Arrays; Perfusion-Based Microfluidic Devices; Droplet-Based Microfluidic Systems; Gradient Generating Microfluidic Devices
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; Corning Incorporated; Lonza Group AG; Sartorius AG; Hamilton Company; CELLINK AB; Creative Bioarray Inc.; InSphero AG; Creative Biolabs Inc.; Mimetas B.V.; REPROCELL Inc.; Synthecon Incorporated; Advanced Solutions Life Sciences LLC; Cherry Biotech SAS; celVivo ApS; Elveflow; Guangzhou Jet Bio-Filtration Co. Ltd.; Organovo Holdings Inc.; Alfa Cytology Co. Ltd.
  • Countries:

Table of Contents

1. Executive Summary

2. Scaffold Free 3D Cell Culture Market Characteristics

3. Scaffold Free 3D Cell Culture Market Trends And Strategies

4. Scaffold Free 3D Cell Culture Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Scaffold Free 3D Cell Culture Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Scaffold Free 3D Cell Culture PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Scaffold Free 3D Cell Culture Market Growth Rate Analysis
  • 5.4. Global Scaffold Free 3D Cell Culture Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Scaffold Free 3D Cell Culture Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Scaffold Free 3D Cell Culture Total Addressable Market (TAM)

6. Scaffold Free 3D Cell Culture Market Segmentation

  • 6.1. Global Scaffold Free 3D Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 3D Cell Culture Platforms
  • 3D Bioprinting Products
  • 3D Cell Culture Kits
  • Microfluidic Devices
  • 6.2. Global Scaffold Free 3D Cell Culture Market, Segmentation By Cellular Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Stem Cells
  • Adherent Cell Cultures
  • Suspension Cell Cultures
  • Immune Cells
  • 6.3. Global Scaffold Free 3D Cell Culture Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hanging Drop Method
  • Magnetic Levitation
  • Microfluidics
  • 6.4. Global Scaffold Free 3D Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Discovery
  • Regenerative Medicine
  • Tissue Engineering
  • Oncology Research
  • Stem Cell Research
  • 6.5. Global Scaffold Free 3D Cell Culture Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Academic Research Institutions
  • Pharmaceutical And Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Clinics And Hospitals
  • 6.6. Global Scaffold Free 3D Cell Culture Market, Sub-Segmentation Of 3D Cell Culture Platforms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hanging Drop Plates
  • Low-Adhesion Microplates
  • Ultra-Low Attachment (ULA) Plates And Flasks
  • Spheroid Culture Dishes
  • Spinner Flasks And Bioreactors
  • Suspension Culture Systems
  • 6.7. Global Scaffold Free 3D Cell Culture Market, Sub-Segmentation Of 3D Bioprinting Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bioprinters
  • Bioinks
  • Printheads And Nozzles
  • Printing Software
  • Consumables And Accessories
  • 6.8. Global Scaffold Free 3D Cell Culture Market, Sub-Segmentation Of 3D Cell Culture Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Spheroid Formation Kits
  • Organoid Culture Kits
  • Co-Culture Kits
  • Tumor Model Kits
  • Stem Cell Differentiation Kits
  • Assay-Ready 3D Cell Culture Kits
  • 6.9. Global Scaffold Free 3D Cell Culture Market, Sub-Segmentation Of Microfluidic Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Organ-On-A-Chip Systems
  • Lab-On-A-Chip Platforms
  • Microchamber Arrays
  • Perfusion-Based Microfluidic Devices
  • Droplet-Based Microfluidic Systems
  • Gradient Generating Microfluidic Devices

7. Scaffold Free 3D Cell Culture Market Regional And Country Analysis

  • 7.1. Global Scaffold Free 3D Cell Culture Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Scaffold Free 3D Cell Culture Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Scaffold Free 3D Cell Culture Market

  • 8.1. Asia-Pacific Scaffold Free 3D Cell Culture Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Scaffold Free 3D Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Scaffold Free 3D Cell Culture Market, Segmentation By Cellular Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Scaffold Free 3D Cell Culture Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Scaffold Free 3D Cell Culture Market

  • 9.1. China Scaffold Free 3D Cell Culture Market Overview
  • 9.2. China Scaffold Free 3D Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Scaffold Free 3D Cell Culture Market, Segmentation By Cellular Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Scaffold Free 3D Cell Culture Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Scaffold Free 3D Cell Culture Market

  • 10.1. India Scaffold Free 3D Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Scaffold Free 3D Cell Culture Market, Segmentation By Cellular Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Scaffold Free 3D Cell Culture Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Scaffold Free 3D Cell Culture Market

  • 11.1. Japan Scaffold Free 3D Cell Culture Market Overview
  • 11.2. Japan Scaffold Free 3D Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Scaffold Free 3D Cell Culture Market, Segmentation By Cellular Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Scaffold Free 3D Cell Culture Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Scaffold Free 3D Cell Culture Market

  • 12.1. Australia Scaffold Free 3D Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Scaffold Free 3D Cell Culture Market, Segmentation By Cellular Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Scaffold Free 3D Cell Culture Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Scaffold Free 3D Cell Culture Market

  • 13.1. Indonesia Scaffold Free 3D Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Scaffold Free 3D Cell Culture Market, Segmentation By Cellular Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Scaffold Free 3D Cell Culture Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Scaffold Free 3D Cell Culture Market

  • 14.1. South Korea Scaffold Free 3D Cell Culture Market Overview
  • 14.2. South Korea Scaffold Free 3D Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Scaffold Free 3D Cell Culture Market, Segmentation By Cellular Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Scaffold Free 3D Cell Culture Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Scaffold Free 3D Cell Culture Market

  • 15.1. Western Europe Scaffold Free 3D Cell Culture Market Overview
  • 15.2. Western Europe Scaffold Free 3D Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Scaffold Free 3D Cell Culture Market, Segmentation By Cellular Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Scaffold Free 3D Cell Culture Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Scaffold Free 3D Cell Culture Market

  • 16.1. UK Scaffold Free 3D Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Scaffold Free 3D Cell Culture Market, Segmentation By Cellular Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Scaffold Free 3D Cell Culture Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Scaffold Free 3D Cell Culture Market

  • 17.1. Germany Scaffold Free 3D Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Scaffold Free 3D Cell Culture Market, Segmentation By Cellular Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Scaffold Free 3D Cell Culture Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Scaffold Free 3D Cell Culture Market

  • 18.1. France Scaffold Free 3D Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Scaffold Free 3D Cell Culture Market, Segmentation By Cellular Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Scaffold Free 3D Cell Culture Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Scaffold Free 3D Cell Culture Market

  • 19.1. Italy Scaffold Free 3D Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Scaffold Free 3D Cell Culture Market, Segmentation By Cellular Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Scaffold Free 3D Cell Culture Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Scaffold Free 3D Cell Culture Market

  • 20.1. Spain Scaffold Free 3D Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Scaffold Free 3D Cell Culture Market, Segmentation By Cellular Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Scaffold Free 3D Cell Culture Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Scaffold Free 3D Cell Culture Market

  • 21.1. Eastern Europe Scaffold Free 3D Cell Culture Market Overview
  • 21.2. Eastern Europe Scaffold Free 3D Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Scaffold Free 3D Cell Culture Market, Segmentation By Cellular Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Scaffold Free 3D Cell Culture Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Scaffold Free 3D Cell Culture Market

  • 22.1. Russia Scaffold Free 3D Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Scaffold Free 3D Cell Culture Market, Segmentation By Cellular Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Scaffold Free 3D Cell Culture Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Scaffold Free 3D Cell Culture Market

  • 23.1. North America Scaffold Free 3D Cell Culture Market Overview
  • 23.2. North America Scaffold Free 3D Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Scaffold Free 3D Cell Culture Market, Segmentation By Cellular Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Scaffold Free 3D Cell Culture Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Scaffold Free 3D Cell Culture Market

  • 24.1. USA Scaffold Free 3D Cell Culture Market Overview
  • 24.2. USA Scaffold Free 3D Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Scaffold Free 3D Cell Culture Market, Segmentation By Cellular Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Scaffold Free 3D Cell Culture Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Scaffold Free 3D Cell Culture Market

  • 25.1. Canada Scaffold Free 3D Cell Culture Market Overview
  • 25.2. Canada Scaffold Free 3D Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Scaffold Free 3D Cell Culture Market, Segmentation By Cellular Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Scaffold Free 3D Cell Culture Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Scaffold Free 3D Cell Culture Market

  • 26.1. South America Scaffold Free 3D Cell Culture Market Overview
  • 26.2. South America Scaffold Free 3D Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Scaffold Free 3D Cell Culture Market, Segmentation By Cellular Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Scaffold Free 3D Cell Culture Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Scaffold Free 3D Cell Culture Market

  • 27.1. Brazil Scaffold Free 3D Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Scaffold Free 3D Cell Culture Market, Segmentation By Cellular Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Scaffold Free 3D Cell Culture Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Scaffold Free 3D Cell Culture Market

  • 28.1. Middle East Scaffold Free 3D Cell Culture Market Overview
  • 28.2. Middle East Scaffold Free 3D Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Scaffold Free 3D Cell Culture Market, Segmentation By Cellular Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Scaffold Free 3D Cell Culture Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Scaffold Free 3D Cell Culture Market

  • 29.1. Africa Scaffold Free 3D Cell Culture Market Overview
  • 29.2. Africa Scaffold Free 3D Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Scaffold Free 3D Cell Culture Market, Segmentation By Cellular Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Scaffold Free 3D Cell Culture Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Scaffold Free 3D Cell Culture Market Competitive Landscape And Company Profiles

  • 30.1. Scaffold Free 3D Cell Culture Market Competitive Landscape
  • 30.2. Scaffold Free 3D Cell Culture Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Corning Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Sartorius AG Overview, Products and Services, Strategy and Financial Analysis

31. Scaffold Free 3D Cell Culture Market Other Major And Innovative Companies

  • 31.1. Hamilton Company
  • 31.2. CELLINK AB
  • 31.3. Creative Bioarray Inc.
  • 31.4. InSphero AG
  • 31.5. Creative Biolabs Inc.
  • 31.6. Mimetas B.V.
  • 31.7. REPROCELL Inc.
  • 31.8. Synthecon Incorporated
  • 31.9. Advanced Solutions Life Sciences LLC
  • 31.10. Cherry Biotech SAS
  • 31.11. celVivo ApS
  • 31.12. Elveflow
  • 31.13. Guangzhou Jet Bio-Filtration Co. Ltd.
  • 31.14. Organovo Holdings Inc.
  • 31.15. Alfa Cytology Co. Ltd.

32. Global Scaffold Free 3D Cell Culture Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Scaffold Free 3D Cell Culture Market

34. Recent Developments In The Scaffold Free 3D Cell Culture Market

35. Scaffold Free 3D Cell Culture Market High Potential Countries, Segments and Strategies

  • 35.1 Scaffold Free 3D Cell Culture Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Scaffold Free 3D Cell Culture Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Scaffold Free 3D Cell Culture Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제